Timothy K. Lu
CIK: 0001852301
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Senti Biosciences Holdings, Inc.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Oct 21, 2026SNTI
Senti Biosciences Holdings, Inc.
Tax Payment(F)Direct157.3K shares- - Mar 9, 2026SNTI
Senti Biosciences, Inc.
Tax Payment(F)Direct80.7K shares- - Feb 2, 2026SNTI
Senti Biosciences, Inc.
Tax Payment(F)Direct4.2K shares- - Mar 7, 2025SNTI
Senti Biosciences, Inc.
Award(A)Direct642.4K shares- - Mar 6, 2025SNTI
Senti Biosciences, Inc.
Award(A)DirectStock Option (Right to Buy)
1.9M shares- - Feb 6, 2025SNTI
Senti Biosciences, Inc.
Sale(S)Direct545 shares at avg. $4.36$2K - Feb 4, 2025SNTI
Senti Biosciences, Inc.
Sale(S)Direct3.9K shares at avg. $4.07$16K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 21, 2026 | SNTI Senti Biosciences Holdings, Inc. | Tax Payment(F) | 157,312 | - | $0 | Direct |
| Mar 9, 2026 | SNTI Senti Biosciences, Inc. | Tax Payment(F) | 80,666 | - | $0 | Direct |
| Feb 2, 2026 | SNTI Senti Biosciences, Inc. | Tax Payment(F) | 4,191 | - | $0 | Direct |
| Mar 7, 2025 | SNTI Senti Biosciences, Inc. | Award(A) | 642,358 | - | - | Direct |
| Mar 6, 2025 | SNTI Senti Biosciences, Inc. | Award(A) Stock Option (Right to Buy) | 1,927,073 | - | - | Direct |
| Feb 6, 2025 | SNTI Senti Biosciences, Inc. | Sale(S) | 545 | $4.36 | $2,376 | Direct |
| Feb 4, 2025 | SNTI Senti Biosciences, Inc. | Sale(S) | 3,922 | $4.07 | $15,963 | Direct |
1-7 of 7 transactions
About Lu Timothy K
Lu Timothy K (SEC CIK 0001852301) files insider reports with the SEC as CEO of Senti Biosciences Holdings, Inc. (SNTI).
Signal8 holds 5 ownership filings by Lu Timothy K, all Form 4s, filed between Feb 6, 2025 and Oct 23, 2026. Those filings report 7 transactions, from Feb 4, 2025 to Oct 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lu Timothy K's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Lu Timothy K
- Oct 21, 2026: Tax withholding of SNTI shares (Form 4, code F).
- Mar 9, 2026: Tax withholding of SNTI shares (Form 4, code F).
- Feb 2, 2026: Tax withholding of SNTI shares (Form 4, code F).
- Mar 7, 2025: Grant or award of SNTI shares (Form 4, code A).
- Mar 6, 2025: Grant or award of SNTI derivative securities (Form 4, code A).
Other insiders filing for Senti Biosciences Holdings, Inc. (SNTI)
- Rajangam Kanya, Pres. & Chief Med. & Dev. Off.
- Baum Bryan Daniel, Director
- Collins James J., Director
- Hsiung Feng, Director
- Schulz Fran, Director
- COOPERSTONE BRENDA, Director